IP Library Granted Patent US 9,862,755
Granted Patent B2
US 9,862,755 · App. 14/224,525 · Granted Jan 9, 2018

High affinity T cell receptor and use thereof

Inventors: Dolores Jean Schendel (Munich, DE); Susanne Wilde (Munich, DE); Bernhard Frankenberger (Munich, DE); Wolfgang Uckert (Berlin, DE)
Assignee: MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN
C07K14/7051A61K35/17A61K38/1774C12N15/85C07K2319/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,862,755
App. No.
14/224,525
Granted
Jan 9, 2018
Kind
B2
Abstract

The present invention is directed to a high affinity T cell receptor (TCR) against a tumor-associated antigen, an isolated nucleic acid molecule encoding same, a T cell expressing said TCR, and a pharmaceutical composition for use in the treatment of diseases involving malignant cells expressing said tumor-associated antigen.

Claims (13)

1. A functional TCR α and/or β-chain fusion protein, comprising:

a) at least one epitope-tag, and

b) the amino acid sequence of an α and/or β-chain of a TCR, wherein the TCR binds to a tyrosinase peptide comprising the amino acid sequence of YMDGTMSQV (SEQ ID NO: 9), wherein the amino acid sequence of the α and/or β-chain of the TCR is encoded by:

i) a nucleic acid molecule coding for the V(D)J regions of a TCR that recognizes tyrosinase and comprises the nucleic acid sequence of SEQ ID NO: 1 coding for the α-chain and/or the nucleic acid sequence of SEQ ID NO: 2 coding for the β-chain of said TCR;

ii) a derivative of the nucleic acid molecule of i), coding for the α- or β-chain, wherein the chain has been altered by one or more additions, deletions, or conservative substitutions of from 1-15 amino acids, the additions, deletions, or conservative substitutions being outside the CDR3 region of each chain; or

iii) a nucleic acid molecule coding for the V(D)J regions of a TCR that recognizes tyrosinase and comprising a CDR3 region encoded by the nucleic acid sequence of SEQ ID NO: 3 or 4 or having the amino acid sequence of SEQ ID NO: 5 or 6,

wherein said epitope-tag is selected from

i) an epitope-tag added to the N- and/or C-terminus of said α and/or β chain, or added into the α and/or β chain sequence, but outside the CDR3 region,

ii) an epitope-tag inserted into a constant region of said α and/or β chain, and

iii) an epitope-tag replacing a number of amino acids in a constant region of said α and/or β-chain.

2. The functional TCR α and/or β-chain fusion protein of claim 1 , wherein the amino acid sequence of the α and/or β-chain of the TCR is encoded by a nucleic acid molecule coding for the V(D)J regions of a TCR that recognizes tyrosinase and comprising the nucleic acid sequence of SEQ ID NO: 1 coding for the α-chain and/or the nucleic acid sequence of SEQ ID NO: 2 coding for the β-chain of said TCR.

3. The functional TCR α and/or β-chain fusion protein of claim 1 , wherein the epitope-tag is selected from the group consisting of CD20-tag, Her2/neu-tag, myc-tag, FLAG-tag, T7-tag, HA-tag, His-tag, S-tag, GST-tag, and GFP-tag.

4. The functional TCR α and/or β-chain fusion protein of claim 1 , wherein the amino acid sequence of the α and/or β-chain of the TCR is encoded by a nucleic acid molecule coding for the V(D)J regions of a TCR that recognizes tyrosinase and comprising a CDR3 region encoded by the nucleic acid sequence of SEQ ID NO: 3 or 4 or having the amino acid sequence of SEQ ID NO: 5 or 6.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2017
From: SCHENDEL, DOLORES; WILDE, SUSANNE; FRANKENBERGER, BERNHARD; UCKERT, WOLFGANG
To: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
Reel/Frame 043060/0509 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2017
From: HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH
To: MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN
Reel/Frame 043060/0527 →
Priority Claims (1)
EP 08020396 · Nov 24, 2008 · regional
Continuity (2)
Division 13130665
Related Publication 20140348805A1 · Nov 27, 2014